Table 3 characteristics of radiotherapy alone group and radiotherapy combined with chemotherapy group after matching
Characteristics | Radiotherapy alone | CTRT | ||||
|---|---|---|---|---|---|---|
AC (n = 15) | SCC(n = 15) | P value | AC(n = 282) | SCC(n = 282) | P value | |
age (%) | 0.833 | 0.901 | ||||
< 40 | 2 (13.3) | 2 (13.3) | 41 (14.5) | 41 (14.5) | ||
40–49 | 5 (33.3) | 6 (40.1) | 98 (34.8) | 100 (35.5) | ||
50–59 | 4(26.7) | 2 (13.3) | 79 (28.0) | 84 (29.8) | ||
60–69 | 4(26.7) | 5 (33.3) | 64 (22.7) | 57 (20.2) | ||
race (%) | 0.648 | 0.969 | ||||
Black | 2 (13.3) | 4(26.7) | 27 (9.6) | 27 (9.6) | ||
White | 13 (86.7) | 11 (73.3) | 36 (12.8) | 38 (13.5) | ||
Other | 0 (0.0) | 0 (0.0) | 219 (77.6) | 217 (76.9) | ||
grade (%) | 1.000 | 0.991 | ||||
I | 0 (0.0) | 0 (0.0) | 33 (11.7) | 34 (12.1) | ||
II | 4(26.7) | 5 (33.3) | 116 (41.1) | 114 (40.4) | ||
III | 11 (73.3) | 10 (66.7) | 124 (44.0) | 126 (44.7) | ||
IV | 0 (0.0) | 0 (0.0) | 9 (3.2) | 8 (2.8) | ||
FIGO stage (%) | 0.970 | 0.012 | ||||
Ib2 | 2 (13.3) | 1 (6.7) | 45 (16.0) | 25 (8.9) | ||
IIa1 | 1 (6.7) | 1 (6.7) | 5 (1.8) | 5 (1.8) | ||
IIa2 | 0 (0.0) | 1 (6.7) | 11 (3.9) | 7 (2.5) | ||
IIb | 2 (13.3) | 2 (13.3) | 77 (27.3) | 68 (24.1) | ||
IIIa | 1 (6.7) | 1 (6.7) | 10 (3.5) | 9 (3.2) | ||
IIIb | 7 (46.7) | 7 (46.7) | 127 (45.0) | 146 (51.7) | ||
IVa | 2 (13.3) | 2 (13.3) | 7 (2.5) | 22 (7.8) | ||
Radiation (%) | 0.766 | 0.545 | ||||
Beam radiation | 11 (73.3) | 11 (73.3) | 100 (35.5) | 91 (32.3) | ||
brachytherapy | 2 (13.3) | 3 (20.0) | 146 (51.7) | 159 (56.4) | ||
BRB | 2 (13.3) | 1 (6.7) | 36 (12.8) | 32 (11.3) | ||
status (%) | 1.000 | 0.542 | ||||
alive | 9 (60.0) | 9 (60.0) | 181 (64.2) | 173 (61.3) | ||
dead | 6(40.0) | 6(40.0) | 101(35.8) | 109(38.7) | ||
time(mean(SD)) | 40.4 (32.5) | 26.1(18.6) | 0.150 | 33.5 (21.6) | 31.8 (22.5) | 0.353 |